Is METS-IR a novel score to evaluate insulin sensitivity?

The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by Bello-Chavolla et al in 2018. METS-IR is a novel score to evaluate cardiometabolic risk in healthy and at-risk subjects and a promising tool for screening of insulin sensitivity. 

METS-IR levels are significantly associated with pre-HTN or HTN in normoglycemia individuals in Gifu, Japan. 

METS-IR is calculated as Ln((2*G₀)+TG₀)*BMI)/(Ln(HDL-c)) (G₀: fasting glucose, TG₀: fasting triglycerides, BMI: body mass index, HDL-c: high-density lipoprotein cholesterol).

 METS-IR also predicts visceral fat content, subcutaneous adipose tissue, fasting insulin levels and ectopic fat accumulation in liver and pancreas.